Logo image of KBSX

FST CORP (KBSX) Stock Fundamental Analysis

NASDAQ:KBSX - Nasdaq - KYG3R23E1004 - Common Stock - Currency: USD

1.74  +0.01 (+0.58%)

After market: 1.73 -0.01 (-0.57%)

Fundamental Rating

1

Overall KBSX gets a fundamental rating of 1 out of 10. We evaluated KBSX against 30 industry peers in the Leisure Products industry. KBSX has a bad profitability rating. Also its financial health evaluation is rather negative. KBSX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KBSX had negative earnings in the past year.
KBSX had a negative operating cash flow in the past year.
KBSX Yearly Net Income VS EBIT VS OCF VS FCFKBSX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.60%, KBSX is doing worse than 63.33% of the companies in the same industry.
The Return On Equity of KBSX (-9.63%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -8.6%
ROE -9.63%
ROIC N/A
ROA(3y)-4.76%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KBSX Yearly ROA, ROE, ROICKBSX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 0 0 0 0 0 0 0 0 0 0

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KBSX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KBSX Yearly Profit, Operating, Gross MarginsKBSX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for KBSX has been reduced compared to 1 year ago.
The debt/assets ratio for KBSX is higher compared to a year ago.
KBSX Yearly Shares OutstandingKBSX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M
KBSX Yearly Total Debt VS Total AssetsKBSX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

KBSX has an Altman-Z score of 12.42. This indicates that KBSX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 12.42, KBSX belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that KBSX is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.04, KBSX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 12.42
ROIC/WACCN/A
WACCN/A
KBSX Yearly LT Debt VS Equity VS FCFKBSX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

KBSX has a Current Ratio of 0.01. This is a bad value and indicates that KBSX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.01, KBSX is not doing good in the industry: 96.67% of the companies in the same industry are doing better.
A Quick Ratio of 0.01 indicates that KBSX may have some problems paying its short term obligations.
The Quick ratio of KBSX (0.01) is worse than 96.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
KBSX Yearly Current Assets VS Current LiabilitesKBSX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for KBSX have decreased strongly by -211.81% in the last year.
EPS 1Y (TTM)-211.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-72.77%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KBSX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KBSX Price Earnings VS Forward Price EarningsKBSX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KBSX Per share dataKBSX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KBSX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FST CORP

NASDAQ:KBSX (6/27/2025, 8:00:02 PM)

After market: 1.73 -0.01 (-0.57%)

1.74

+0.01 (+0.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.72%
Inst Owner ChangeN/A
Ins Owners5.27%
Ins Owner ChangeN/A
Market Cap106.45M
AnalystsN/A
Price TargetN/A
Short Float %0.25%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.6
P/tB 2.6
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.67
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.6%
ROE -9.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.76%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 12.42
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-211.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-72.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-89.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.57%
OCF growth 3YN/A
OCF growth 5YN/A